Author Question: A patient who has been diagnosed with human immune deficiency syndrome is given ganciclovir ... (Read 18 times)

penza

  • Hero Member
  • *****
  • Posts: 1,022
A patient who has been diagnosed with human immune deficiency syndrome is given ganciclovir (Cytovene) to prevent cytomegalovirus. The patient develops granulocytopenia.
 
  How long will it take for the granulocytes to regenerate after the ganciclovir is discontinued? A) 5 days
  B) 7 days
  C) 10 days
  D) 14 days

Question 2

A 12-year-old boy has been diagnosed with acute otitis externa. The patient's mother has asked if oral medications might be more effective than ear drops.
 
  The nurse should respond in the knowledge that systemic medications for the treatment of otitis externa are only indicated in what circumstances? A) The infection is accompanied by ear discharge.
  B) The patient is allergic to penicillins.
  C) The patient is unable to self-administer ear drops.
  D) A deep tissue infection develops.



nathang24

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

B
Feedback:
Ganciclovir causes granulocytopenia and thrombocytopenia in 20 to 40 of recipients, often during the first 2 weeks of therapy. If severe bone marrow depression occurs, ganciclovir should be discontinued; recovery usually occurs within a week of stopping the drug. Five days after discontinuing the drug is too soon to see a change in granulocytopenia. Ten to fourteen days is too long for change to occur. It should have occurred within 1 week.

Answer to Question 2

D
Feedback:
For acute otitis externa, use of topical agents, as opposed to systemic agents, is more common. Systemic medications are indicated only if a deep tissue infection develops outside the external canal or if immunocompromised status is an issue. Allergy status, ability to self-administer, and the presence or discharge are not indications for systemic antibiotics.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

For a complete list of videos, visit our video library